[HTML][HTML] Guidance on noncorticosteroid systemic immunomodulatory therapy in noninfectious uveitis: Fundamentals Of Care for UveitiS (FOCUS) initiative

…, CED Merino, A Facsko, L Figueira, A Fonollosa… - Ophthalmology, 2018 - Elsevier
Topic An international, expert-led consensus initiative to develop systematic, evidence-
based recommendations for the treatment of noninfectious uveitis in the era of biologics …

Clinical management algorithm of uveitis associated with juvenile idiopathic arthritis: interdisciplinary panel consensus

…, J Díaz, J Escudero, A Fonollosa… - Rheumatology …, 2015 - Springer
Uveitis associated with juvenile idiopathic arthritis (JIA) typically involves the anterior
chamber segment, follows an indolent chronic course, and presents a high rate of uveitic …

Treatment of refractory uveitis with adalimumab: a prospective multicenter study of 131 patients

…, MJ Rio-Pardo, C Fernandez-Cid, A Fonollosa… - Ophthalmology, 2012 - Elsevier
OBJECTIVE: To evaluate adalimumab therapy in refractory uveitis. DESIGN: Prospective
case series. PARTICIPANTS: A total of 131 patients with refractory uveitis and intolerance or …

Interleukin‐8, monocyte chemoattractant protein‐1 and IL‐10 in the vitreous fluid of patients with proliferative diabetic retinopathy

C Hernandez, RM Segura, A Fonollosa… - Diabetic …, 2005 - Wiley Online Library
Aims To determine the intra‐vitreous levels of two pro‐inflammatory cytokines [interleukin‐8
(IL‐8), monocyte chemoattractant protein‐1 (MCP‐1)] and the anti‐inflammatory cytokine …

Characterizing covid-19–related retinal vascular occlusions: A case series and review of the literature

A Fonollosa, J Hernández-Rodríguez, C Cuadros… - Retina, 2022 - journals.lww.com
Purpose: To describe clinical and ophthalmologic features and outcomes of patients with
coronavirus disease-19 with retinal vascular occlusions. Methods: Retrospective multicenter …

Anti-TNF-α therapy in patients with refractory uveitis due to Behçet's disease: a 1-year follow-up study of 124 patients

…, N Ortego, JM Herreras, A Fonollosa… - …, 2014 - academic.oup.com
Objective. The aim of this study was to assess the efficacy of anti-TNF-α therapy in refractory
uveitis due to Behçet's disease (BD). Methods. We performed a multicentre study of 124 …

Erythropoietin is expressed in the human retina and it is highly elevated in the vitreous fluid of patients with diabetic macular edema

C Hernández, A Fonollosa, M García-Ramírez… - Diabetes …, 2006 - Am Diabetes Assoc
OBJECTIVE—Erythropoietin has been recently found to be increased in the vitreous fluid
from ischemic retinal diseases such as proliferative diabetic retinopathy (PDR). The aims of …

Multicenter study of intravitreal dexamethasone implant in noninfectious uveitis: indications, outcomes, and reinjection frequency

…, Q Mohammed, AH Ross, C Barker, A Fonollosa… - American journal of …, 2014 - Elsevier
Purpose To identify clinical outcomes and treatment patterns of intravitreal dexamethasone
implant (Ozurdex; Allergan, Inc) in noninfectious uveitis in the clinical setting. Design …

Comparative study of infliximab versus adalimumab in refractory uveitis due to Behçet's disease: national multicenter study of 177 cases

…, JM Herreras, A Fonollosa… - Arthritis & …, 2019 - Wiley Online Library
Objective To compare the efficacy of infliximab (IFX) versus adalimumab (ADA) as a first‐line
biologic drug over 1 year of treatment in a large series of patients with refractory uveitis due …

Anti-TNF-α therapy in refractory uveitis associated with sarcoidosis: Multicenter study of 17 patients

…, S González-Suárez, A Fonollosa… - Seminars in arthritis and …, 2015 - Elsevier
Objectives To assess anti-TNF-α therapy response in uveitis associated with sarcoidosis
refractory to conventional immunosuppressive therapy. Methods Open-label, multicenter …